Article
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
10 Apr 2019
Abstract excerpt
Abstract Therapies that target the function of immune cells have significant clinical efficacy in diseases such as cancer and autoimmunity. Although functional genomics has accelerated therapeutic target discovery in cancer, its use in primary immune cells is limited because vector delivery is inefficient and can perturb cell states. Here we describe CHIME: CHimeric IMmune Editing, a CRISPR-Cas9 bone marrow...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
